Related Experiment Video
Updated: Jul 12, 2025

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Kinesiophobia and Associated Factors in Patients With Myocardial Infarction
Hazal Yakut Ozdemir1, Sevgi Ozalevli2, Elvan Felekoglu3
1Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Izmir Deomkrasi University, Izmir, Turkey.
Abstract:
Kinesiophobia is a well-known barrier to positive clinical outcomes among patients with various diseases, but there remain few comprehensive studies of kinesiophobia among patients with myocardial infarction (MI). In this cross-sectional study, we investigated the presence of kinesiophobia and its relationship with clinical outcomes among 42 patients with MI who completed the Tampa Scale of Kinesiophobia Swedish Version for Heart (TSK-SV Heart) the International Physical Activity Questionnaire-Short Form (IPAQ-SF), the Six-Minute Walk Test (6MWT), the Hospital Anxiety and Depression Scale (HADS), the modified Medical Research Council (mMRC) Dyspnea Scale, the Charlson Comorbidity Index (CCI), and the MacNew Heart Disease Health-Related Quality of Life Questionnaire. The participants' mean TSK-SV Heart score was 39.24 (SD = 6.65), and 71.4% of these patients reported a high level of kinesiophobia. The TSK-SV Heart score demonstrated a strong correlation with the IPAQ-SF, 6MWT walking distance, and mMRC score (p < .001), and a moderate correlation with the HADS, CCI, and MacNew Heart Disease HRQoL (p < .05). Patients with a high level of kinesiophobia had lower IPAQ-SF, 6MWT walking distance, and HRQoL and higher mMRC, CCI, and HADS scores than patients with low levels of kinesiophobia (p < .05). Kinesiophobia was common and represented a considerable risk factor for physical-psychosocial dysfunctions in these patients with MI. To maintain functional independence and to increase physical activity level, clinicians should consider kinesiophobia from early to late-stage disease and should add a treatment focus that seeks to eliminate kinesiophobia in cardiac rehabilitation programs.
Insights
Kinesiophobia, or fear of movement, is prevalent in myocardial infarction (MI) patients, negatively impacting physical activity and quality of life. Addressing this fear is crucial for improving clinical outcomes in cardiac rehabilitation.
Area of Science:
- Cardiology
- Psychology
- Rehabilitation Medicine
Background:
- Kinesiophobia is a known barrier to recovery in various conditions.
- Limited research exists on kinesiophobia in myocardial infarction (MI) patients.
- Understanding kinesiophobia's impact is vital for optimizing cardiac patient care.
Purpose of the Study:
- To investigate the prevalence of kinesiophobia in MI patients.
- To examine the relationship between kinesiophobia and clinical outcomes.
- To assess the correlation with physical activity, quality of life, and psychological distress.
Main Methods:
- Cross-sectional study of 42 MI patients.
- Utilized TSK-SV Heart, IPAQ-SF, 6MWT, HADS, mMRC, CCI, and MacNew HRQoL questionnaires.
- Correlational analysis to assess relationships between variables.
Main Results:
- High kinesiophobia (71.4%) was observed in MI patients (mean TSK-SV Heart score: 39.24).
- Kinesiophobia strongly correlated with physical activity (IPAQ-SF, 6MWT) and dyspnea (mMRC).
- High kinesiophobia was linked to lower quality of life and higher anxiety, depression, and comorbidity scores.
Conclusions:
- Kinesiophobia is common in MI patients and a significant risk factor for physical and psychosocial dysfunction.
- Early and late-stage intervention for kinesiophobia is recommended in cardiac rehabilitation.
- Targeting kinesiophobia can enhance functional independence and physical activity levels in MI survivors.
More Related Videos
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Angina I: Introduction
Myocarditis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina III: Clinical Manifestations and Assessment
Myocarditis III: Medical Management

